KYC review queue, OCR-extracted entity cards, beneficial-owner graph, and continuous sanctions screening for the focus entity. Tier-tracking continues from /methodology/verification.
Preview · live at Q3 2026
All data fictional · concept reference
app.afrosynergy.com/platform-preview/verification
Mock
Review queue
Entity cards
Sanctions log
Tier history
Open KYC reviews
5
Avg age 5.0d
OCR ≥ 90% confidence
73%
last 30d
Sanctions scans · 24h
14,820
0 hard flags
Adverse-media events
2
both clear
Document review queue
KYC-44012
Kumasi Premium Cocoa Co-op
Assigned · A. Mensah
T2→T3
Bylaws · Tax · Audited 2025 · 3 refs
OCR
96%
Age
3d
KYC-44017
Stellenbosch Solar Pty
Assigned · L. Naidoo
T2→T3
CIPC · Tax · 2 refs · awaiting audit
OCR
88%
Age
5d
KYC-44021
Mauritius Generics SE
Assigned · P. Ramgoolam
T3→T4
BAA · Reg.licence · DPA · UBO map · audit
OCR
99%
Age
11d
KYC-44024
Lobito Copper Concentrate
Assigned · J. Neto
T2→T3
Reg cert · awaiting financials + refs
OCR
72%
Age
1d
KYC-44029
Cairo Pharma Distribution
Assigned · S. Tawfik
T1→T2
CR · KYC · bank conf · awaiting sector licence
OCR
91%
Age
6h
OCR-extracted entity card · focus
KYC-44021 · MU
Mauritius Generics SE
Tier 3 verified
Entity type
Pharmaceutical manufacturer
Founded
2018
Staff (declared)
142
Audited financials
2024 · 2025
Beneficial ownership · upgrade request to Tier 4
P1Indian Ocean Pharma Hldgs54%
P2Africa Health Capital LLP28%
P3Founder family trust18%
Ultimate beneficial owners
P. RamgoolamT3
S. DeviT3
R. PillaiT3
D. Kumar Trust (estate)T2
Built · this workflow is implemented in the product; the live surface may evolve through the Q3 2026 launch
Illustrative · every counterparty, deal ID and figure on this mock is fictional — no production data is shown